Chongsathidkiet Pakawat, Jackson Christina, Koyama Shohei, Loebel Franziska, Cui Xiuyu, Farber S Harrison, Woroniecka Karolina, Elsamadicy Aladine A, Dechant Cosette A, Kemeny Hanna R, Sanchez-Perez Luis, Cheema Tooba A, Souders Nicholas C, Herndon James E, Coumans Jean-Valery, Everitt Jeffrey I, Nahed Brian V, Sampson John H, Gunn Michael D, Martuza Robert L, Dranoff Glenn, Curry William T, Fecci Peter E
Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Nat Med. 2019 Mar;25(3):529. doi: 10.1038/s41591-019-0355-0.
In the version of this article originally published, the figure callout in this sentence was incorrect: "Furthermore, in S1P1-KI mice themselves, whereas PD-1 blockade was ineffectual as monotherapy, the effects of 4-1BB agonism and checkpoint blockade proved additive, with the combination prolonging median survival and producing a 50% long-term survival rate (Fig. 6f)." The callout should have been to Supplementary Fig. 6b. The error has been corrected in the PDF and HTML versions of the article.
在本文最初发表的版本中,该句子中的图注有误:“此外,在S1P1-KI小鼠本身中,虽然PD-1阻断作为单一疗法无效,但4-1BB激动剂和检查点阻断的效果被证明是相加的,联合使用可延长中位生存期并产生50%的长期生存率(图6f)。” 该图注应为补充图6b。此错误已在文章的PDF和HTML版本中得到纠正。